CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nephro Care India Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nephro Care India Ltd
Phone: +91 8069841500p:+91 8069841500 KOLKATA, 700098  India Ticker: NEPHROCARENEPHROCARE

Business Summary
Nephro Care India Limited is an India-based healthcare provider that specializes in the treatment of kidney-related diseases. The Company’s main business is to provide a comprehensive 360-degree healthcare service to patients with kidney-related services. The Company offers a range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The Company offers various services at its clinics, including Inhouse Dialysis Unit; Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology; NABL accredited inhouse Pathology; Inhouse Pharmacy; Advanced diagnostic facilities; Renal Nutrition department; Home Care; Mukti (Lifestyle Support Program), and Home Dialysis. It also offers other services, such as Pulmonary function test, EMG/NCV-testing, Uroflowmetry-a test, Polysomnography and others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
8092 Kidney dialysis centers

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer SomnathChakraborty 41 10/3/2023 10/3/2023
Chief Financial Officer TapasSaha 41 10/1/2023 10/1/2023
Compliance Officer, Company Secretary SougataSengupta 49 3/9/2024 3/9/2024
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 16,486,400 (As of 12/31/2023)
Stock Exchange: NSE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 10, 2024